Silence Therapeutics plc

Silence Therapeutics plc

Silence Therapeutics wants to put the kibosh on disease-causing genes. The company, formerly known as SR Pharma, is working in the field of RNA interference (RNAi), a cutting-edge approach to treating disease that involves interfering with, or silencing, targeted genes associated with disease. Its AtuPLEX drug delivery system is designed to work specifically with RNA molecules. Silence Therapeutics acquired fellow RNAi research company Intradigm in 2010, greatly expanding its RNAi program capabilities, which it hopes will make it a more attractive partner to bigger pharmaceutical companies looking to develop products based on that science.

Contact Details

Office Address

Silence Therapeutics plc
21 Albemarle Street, London, UK W1S4BS
Phone: +44-20-7491-6520
Fax: +44-20-7491-6521

Executives

Chairman and CEO

Iain G. Ross

Business Reviews for Silence Therapeutics plc

Related Companies